These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Muscle-Specific Kinase Autoimmune Myasthenia Gravis: Report of a Pediatric Case and Literature Review. Ben Younes T; Benrhouma H; Klaa H; Ben Aoun R; Rouissi A; Ben Ahmed M; Kraoua I; Ben Youssef-Turki I Neuropediatrics; 2019 Apr; 50(2):116-121. PubMed ID: 30577044 [TBL] [Abstract][Full Text] [Related]
8. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent. Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288 [TBL] [Abstract][Full Text] [Related]
14. What's in the serum of seronegative MG and LEMS?: MuSK et al. Abicht A; Lochmüller H Neurology; 2002 Dec; 59(11):1672-3. PubMed ID: 12473750 [No Abstract] [Full Text] [Related]
15. MuSK antibody positive myasthenia gravis in a 38-year old West Indian female. Ramcharan K; Bahall M; Bodoe C; Khan S; Ewe P; Sharma S West Indian Med J; 2011 Dec; 60(6):694-5. PubMed ID: 22512235 [No Abstract] [Full Text] [Related]
16. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Guptill JT; Sanders DB; Evoli A Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519 [TBL] [Abstract][Full Text] [Related]
17. An update on laboratory diagnosis in myasthenia gravis. Oger J; Frykman H Clin Chim Acta; 2015 Sep; 449():43-8. PubMed ID: 26238187 [TBL] [Abstract][Full Text] [Related]
18. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis. Jordan B; Schilling S; Zierz S J Neurol; 2016 Jan; 263(1):174-6. PubMed ID: 26645394 [No Abstract] [Full Text] [Related]
19. Rethinking the utility of acetylcholine receptor antibody titer as a pharmacodynamic biomarker for myasthenia gravis. Lee I; Sanders D Muscle Nerve; 2021 Oct; 64(4):385-387. PubMed ID: 34287983 [No Abstract] [Full Text] [Related]
20. Comment: Is 3,4-DAP a new option in treating MuSK MG? Hobson-Webb LD Neurology; 2016 Mar; 86(11):1071. PubMed ID: 26873955 [No Abstract] [Full Text] [Related] [Next] [New Search]